“…Although the inclusion of Ag/Ab assays in the algorithm allows reduction of the diagnostic window, they fail to identify participants in Fiebig stage I, a situation where early treatment could potentially provide additional benefits in regard to the reservoir's size [20,21]. The above mentioned molecular techniques are usually expensive, so, alternative approaches such as pooling are proposed as a way to increase its cost-effectiveness [28]. In our study, the estimated that the HIV prevalence was 19.6% which is lower than the previously reported 34% in the country for TGW [2,3,1].…”